Amsurg Reaches New 52-Week High (AMSG)

NEW YORK ( TheStreet) -- Amsurg Corporation (Nasdaq: AMSG) hit a new 52-week high Wednesday as it is currently trading at $28.72, above its previous 52-week high of $28.33 with 31,473 shares traded as of 9:48 a.m. ET. Average volume has been 138,500 shares over the past 30 days.

Amsurg has a market cap of $839.6 million and is part of the health care sector and health services industry. Shares are up 3.5% year to date as of the close of trading on Tuesday.

AmSurg Corp., through its subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers (ASC) in partnership with physicians in the United States. The company has a P/E ratio of 16.2, below the average health services industry P/E ratio of 16.6 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Amsurg as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Amsurg Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.
null

If you liked this article you might like

Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios

Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios

'Mad Money' Lightning Round: Kroger, Dunkin' Brands

'Mad Money' Lightning Round: Kroger, Dunkin' Brands

Jim Cramer's 'Mad Money' Recap: Trump Trade War Could Hit U.S. Car, Apple iPhone Sales

Jim Cramer's 'Mad Money' Recap: Trump Trade War Could Hit U.S. Car, Apple iPhone Sales

Analysts' Actions -- Tableau, Nucor, Pfizer, Square and More

Analysts' Actions -- Tableau, Nucor, Pfizer, Square and More

Mednax Remains Unlikely Target as Medical Mergers Gain Steam

Mednax Remains Unlikely Target as Medical Mergers Gain Steam